<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04853173</url>
  </required_header>
  <id_info>
    <org_study_id>2020/542</org_study_id>
    <nct_id>NCT04853173</nct_id>
  </id_info>
  <brief_title>Modality of Pain Management in Ambulatory Tonsillectomy Surgery in Adults</brief_title>
  <acronym>DACAA</acronym>
  <official_title>Modality of Pain Management in Ambulatory Tonsillectomy Surgery in Adults: External Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      No SFORL recommendation for adult ambulatory tonsillectomy. This study would allow the&#xD;
      establishment of an ambulatory management during an adult tonsillectomy. This would allow a&#xD;
      return home from J0 for the patient and therefore would improve the comfort of the patients&#xD;
      and reduce the cost associated with a conventional hospitalization over several days.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 28, 2021</start_date>
  <completion_date type="Anticipated">November 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 28, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Assess pain management modalities in adult outpatient tonsillectomy surgery</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess pain management modalities in ambulatory tonsillectomy surgery in adults through post-operative pain assessment, with a defined analgesia and anesthesia protocol adapted to ambulatory management.</measure>
    <time_frame>14 days</time_frame>
    <description>Pain measured by self-assessment by Analog Visual Scale (0-10). If score is under 4 = efficacity of ansthesia protocol</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Tonsillar Disorder</condition>
  <arm_group>
    <arm_group_label>ambulatory protocol after adult tonsillectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>prescription of analgesics for outpatient procedure with hospital surveillance</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Assess pain management modalities in adult outpatient tonsillectomy surgery</intervention_name>
    <description>use a post-operative analgesia protocol suitable for outpatient surgery. Namely a protocol of analgesia based on the taking of drugs per bone (by mouth) and not intravenous. Pain evaluation.</description>
    <arm_group_label>ambulatory protocol after adult tonsillectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  programmed Tonsillectomy surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Congenital or acquired hemostasis disorder&#xD;
&#xD;
          -  Indication of uvulo-bike-pharyngo-plasty&#xD;
&#xD;
          -  Contraindication to the use of one of the protocol molecules including pregnancy&#xD;
&#xD;
          -  Allergy to analgesic treatments used in the study&#xD;
&#xD;
          -  Ongoing analgesic treatment that cannot be interrupted&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurent TAVERNIER, PU-PH</last_name>
    <phone>0381669360</phone>
    <email>ltavernier@chu-besancon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent TAVERNIER</last_name>
      <phone>0381669360</phone>
      <email>ltavernier@chu-besancon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 16, 2021</study_first_submitted>
  <study_first_submitted_qc>April 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

